CRO Strategies For Accelerating Drug Development With Precision Micro-Dosing Technology

Click Here To Download:
•Case Study: CRO Strategies For Accelerating Drug Development With Precision Micro-Dosing Technology

Small molecule developers of all sizes face increasing pressure to maximize the profitability of pipeline products by adopting aggressive drug development timelines and finding solutions to the challenge of poor clinical trials results attributable to formulation. In response, forward-thinking contract research organizations have aligned their scientific expertise and service offerings with access to proprietary technology, offering clients ready-made strategies for overcoming these common challenges.

Direct encapsulation of active pharmaceutical ingredient provides an expedited strategy to first-in-man clinical studies, and can be more efficient than development efforts that result in a full formulation. The ability to deliver micro-dose amounts of drug substance eliminates the need for preformulation and excipient compatibility studies, but clients may still need to rely upon CRO expertise to overcome unacceptable physical properties associated with their API.

Click Here To Download:
•Case Study: CRO Strategies For Accelerating Drug Development With Precision Micro-Dosing Technology